Keywords
How to Cite
Abstract
. Improvement of prevention is impossible without the development and implementation of the most optimal ways of providing medical care to create a regulatory framework that regulates the provision of medical care at all levels. High-level scientific and medical information is summarized in clinical guidelines (clinical guidelines), which are the source of standards of care.
Aim: To substantiate the application of a clinico-organizational approach to improving the prevention of epidermal dysplasia by developing a clinical algorithm for medical care for patients with epidermal dysplasia based on a process approach. Using the provisions of international standards of care.
Material and Methods: The data of persons receiving medical care at the State Scientific Institution “Scientific and Practical Centre of Preventive andClinical Medicine” of the State Administrationduring 2014 to half of the 2019 were used. A retrospective analysis of scientific literature data on topical issues of prevention of epidermal skin dysplasia has been carried out.
Results: Based on the analysis of the scientific literature, we have created a clinical algorithm of medical care for patients with epidermal dysplasia of the skin, which includes the screening stage, the stage of diagnosis and stage of treatment, stage of dynamic observation. In accordance with the tasks of each of the stages in the article the movement of patients is analyzed, frequencies of application of diagnostic and therapeutic methods are given. The functions of each specialist in the stages of the medical algorithm are determined.
Conclusions: Systematization of scientific literature data, analysis of own research results and use of the principles of process approach allowed to substantiate and structure the clinical algorithm of medical care for patients with epidermal dysplasia of the skin.
References
VoronenkoYu. V. (2014). Organizaciya kontrolyuya kostimedichnoyi dopomogi v zakladah ohoroni zdorov’ya: metodichni rekomendaciyi [Organization of quality control of medical care in health care institutions: guidelines] / pidredakciyeyu Yu. V. Voronenko. К., 31. https://pdfs.semanticscholar.org/7909/dcfd4c7a9ef0e9f1500362ed1415bfaca819.pdf
Oshivalova O. O. (2019). Efektivnist vprovadzhennya lokalnogo protokolu medichnoyi dopomogi hvorim na epidermalni displaziyi shkiri u bagatoprofilnomu medichnomu zakladi [Effectiveness of implementation of local protocol of medical care for patients with epidermal skin dysplasia in a multidisciplinary medical institution.]. Bulletin of problems of biology and medicine, 1, (148), 307-313. Available at: https://vpbm.com.ua/en/vyipusk-1-tom-1-(148),-2019/11976.
Dréno B., Amici J. M., Basset-Seguin N., Cribier B., Claudel J. P., Richard M. A. (2014). Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians, 28(9), 1141-1149. https://doi.org/10.1111/jdv.12434.
de Berker D., McGregor J. M., MohdMustapa M. F., Exton L.S., Hughes B. R. (2017). British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis. Br J Dermatol., 176(1), 20-43. https://doi.org/10.1111/bjd.15107.
Kirby J.S., Scharnitz T., Seiverling E. V. Ahrns Н., Ferguson S. (2015). Actinic Keratosis Clinical Practice Guidelines: An Appraisal of Quality. Dermatology Research and Practice, 7, http://dx.doi.org/10.1155/2015/456071.
Morley G. L., Matthews J. H., Verpetinske I.,Thom G. A. (2015). A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia. Dermatol Res Pract, 421-460. doi: 10.1155/2015/421460. Available at: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4579309/.
National Cancer Registry of Ukraine: short description of the database as of January, 2018. Available from: http://www.ncru.inf.ua/publications/index.htm.
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium®) Non-Melanoma Skin Cancers. These NCCN Guidelines® are currently available as Version 1. 2018. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx.
Newlands C., Currie R., Memon A., Whitaker S., Woolford T. (2016). Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol., 130(S2), S125-S132. doi: 10.1017/S0022215116000554. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27841126.
Noels E. C., Hollestein L. M, van Egmond S., Lugtenberg M.,van Nistelrooij L.P.J., Bindels P.J.E., vander LeiJ., Stern R.S., Nijsten T.,Wakkee M. (2019). Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis. British Journal of Dermatology, Jan 12. https://doi.org/10.1111/bjd.17632.
Noels E. C., Lugtenberg M., van Egmond S., Droger S. M., Buis P. A. J., Nijsten Т. (2019). Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists. British Journal of Dermatology, 181(1), 96-104. https://doi.org/10.1111/bjd.17818.
Ortonne J. P. (2002). From actinic keratosis to squamous cell carcinoma. Br J Dermatol, 146(61), 20-23. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11966728.
Ratushny V., Gober M. D., Hick R., Ridky T. W., Seykora J. T. (2012). From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest, 122(2), 464–472. https://doi.org/10.1172/JCI57415.
Stratigos А., Garbe С., Lebbe С., Malvehy J.,del Marmol V., Pehamberger H., Peris K., Becker J. C., Zalaudek I., Saiag P., Middleton M. R., Bastholt L., Testori A., Grob J. J.; European Dermatology Forum (EDF), European Association of Dermato-Oncology (EADO), European Organization for Research and Treatment of Cancer (EORTC). (2015). Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer, 51(14), 1989-2007. https://www.ncbi.nlm.nih.gov/pubmed/26219687
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.